NCT04634617Active, not recruiting
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
Source: ClinicalTrials.gov · Last updated 20 May 2026
Brief summary (registry, in English)
This trial studies pelvic floor dysfunction and quality of life in uterine cancer survivors. Using questionnaires may help researchers learn more about the sexual function and quality of life in uterine cancer survivors.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 310 (actual)
- First submitted
- 9 Nov 2020
- Start date
- 9 Jan 2020
- Primary completion date
- 11 Apr 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Endometrial cancer, Sarcoma
- NCT number
- NCT04634617
What you commit to
- Study type: Observational
- Participants enrolled: 310
- From 9 Jan 2020 to the primary completion date, 11 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with additional pelvic surgery at the time of their hysterectomy (for example pelvic exenteration, urostomy placement, etc.)
- Preoperative radiotherapy prior to hysterectomy
Other illness
- Patients with cancer recurrence, as this will affect their current quality of life
- Patients with a secondary primary cancer (including cervical cancer), as this will affect their current quality of life. Patients may have either squamous cell or basal cell carcinoma of the skin
Other
- Neurocognitive deficits that render patients unable to complete the survey on their own
- Patients who have not yet had removal of their bilateral ovaries
Who the study is looking for
- Patients with uterine cancer (including endometrial and uterine carcinoma or sarcoma) treated with surgery +/- radiation at MD Anderson between 2006 and 2017
- Eligible surgeries include laparoscopic or robotic assisted abdominal total hysterectomy, total abdominal hysterectomy, and vaginal hysterectomy with or without pelvic node dissection, with or without omentectomy or omental biopsies
- In addition, patients must have had all WITH bilateral-salpingo-oophorectomy (BSO), either during their surgery or in a previous or subsequent (within 3 months of endometrial cancer diagnosis) surgery
- Patients have had at least one year of follow-up
- Patients have not had any recurrence of disease
- Patients must be able to complete the survey of their own volition
- Patients must be able to read and speak English fluently
- CONTROL GROUP: Patients have never been diagnosed with any cancer other than non-melanomatous skin cancers
- CONTROL GROUP: Patient has undergone hysterectomy/BSO for benign reasons between 2006 and 2017
- CONTROL GROUP: Patients must be able to complete the survey of their own volition
- CONTROL GROUP: Patients must be able to speak and read English fluently
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.